- Home
- BCTX vs TOMZ Comparison
BCTX vs TOMZ Comparison
Compare BCTX & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- TOMZ
- Stock Information
- Founded
- BCTX 2014
- TOMZ 1979
- Country
- BCTX Canada
- TOMZ United States
- Employees
- BCTX N/A
- TOMZ N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- BCTX Health Care
- TOMZ Finance
- Exchange
- BCTX Nasdaq
- TOMZ Nasdaq
- Market Cap
- BCTX 16.1M
- TOMZ 15.7M
- IPO Year
- BCTX N/A
- TOMZ N/A
- Fundamental
- Price
- BCTX $3.21
- TOMZ $0.84
- Analyst Decision
- BCTX Strong Buy
- TOMZ Strong Buy
- Analyst Count
- BCTX 1
- TOMZ 1
- Target Price
- BCTX $32.00
- TOMZ $3.50
- AVG Volume (30 Days)
- BCTX 3.7M
- TOMZ 16.0K
- Earning Date
- BCTX 06-13-2025
- TOMZ 05-08-2025
- Dividend Yield
- BCTX N/A
- TOMZ N/A
- EPS Growth
- BCTX N/A
- TOMZ N/A
- EPS
- BCTX N/A
- TOMZ N/A
- Revenue
- BCTX N/A
- TOMZ $7,738,842.00
- Revenue This Year
- BCTX N/A
- TOMZ $9.68
- Revenue Next Year
- BCTX N/A
- TOMZ $130.22
- P/E Ratio
- BCTX N/A
- TOMZ N/A
- Revenue Growth
- BCTX N/A
- TOMZ 5.22
- 52 Week Low
- BCTX $0.35
- TOMZ $0.60
- 52 Week High
- BCTX $9.82
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- BCTX 37.63
- TOMZ 57.28
- Support Level
- BCTX $3.09
- TOMZ $0.79
- Resistance Level
- BCTX $9.82
- TOMZ $0.87
- Average True Range (ATR)
- BCTX 0.74
- TOMZ 0.04
- MACD
- BCTX -0.21
- TOMZ 0.01
- Stochastic Oscillator
- BCTX 1.78
- TOMZ 80.69
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.